Skip to main content

Advertisement

Log in

Continuous Processing of Micropellets via Hot-Melt Extrusion

  • Research Article
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

Microparticulate drug delivery systems, e.g., micropellets (MPs), are used in a variety of pharmaceutical formulations such as suspensions, injectable systems, and capsules. MPs are currently manufactured mainly via batch, solvent-based processes, e.g., spray-drying and solvent evaporation-extraction. In this paper, we present a novel, solvent-free, continuous hot-melt extrusion–based approach with an inline cold pelletization step and the potential of unprecedented on-the-fly formulation changes, aiming at producing the smallest particles usable for injectable applications. A biodegradable, crystalline dispersion consisting of poly(DL-lactic acid) (PLA) filled with metformin as the model drug was chosen on purpose to elucidate the broad applicability of the process also to formulations with limited stretchability and complex pelletizability. Next to optical/statistical particle analyses and in-line high-speed camera investigations providing insights into the pelletization process, the injectability of the most promising micropellets was compared to that of one marketed formulation. Fast extrudate haul-off speeds and high numbers of pelletizer knives resulted in particles with a narrow and small particle size distribution with a d50 below 270 µm and aspect ratios close to 1. To omit protruding drug particles to ensure sufficient extrudate stretchability and allow for the smallest MPs, it was found that the d90 of the embedded drug must be significantly below the extrudate diameter. Upon adapting the syringe diameter, the produced micropellets revealed similar injectability parameters to the marketed formulation, showcasing the potential that the proposed setup has for the manufacturing of novel microparticulate formulations.

Graphical Abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

References

  1. Lengyel M, Kállai-Szabó N, Antal V, Laki AJ, Antal I. Microparticles, microspheres, and microcapsules for advanced drug delivery. Sci Pharm. 2019;87

  2. Rogers TL, Wallick D. Reviewing the use of ethylcellulose, methylcellulose and hypromellose in microencapsulation Part 3: Applications for microcapsules. Drug Dev Ind Pharm. 2012;38:521–39.

    Article  CAS  Google Scholar 

  3. Daly AC, Riley L, Segura T, Burdick JA. Hydrogel microparticles for biomedical applications. Nat Rev Mater. Springer US; 2020;5:20–43.

  4. Rao MRP, Borate SG, Thanki KC, Ranpise AA, Parikh GN. Development and in vitro evaluation of floating rosiglitazone maleate microspheres. Drug Dev Ind Pharm. 2009;35:834–42.

    Article  CAS  Google Scholar 

  5. Scalia S, Young PM, Traini D. Solid lipid microparticles as an approach to drug delivery. Expert Opin Drug Deliv. Informa UK, Ltd.; 2015;12:583–99

  6. Gavini E, Rassu G, Sanna V, Cossu M, Giunchedi P. Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies. J Pharm Pharmacol. 2010;57:287–94.

    Article  Google Scholar 

  7. Liu X, Okada M, Maeda H, Fujii S, Furuzono T. Hydroxyapatite/biodegradable poly(l-lactide-co - Caprolactone) composite microparticles as injectable scaffolds by a Pickering emulsion route. Acta Biomater. Acta Materialia Inc. 2011;7:821–8.

  8. Wang Y, Burgess DJ. Long acting injections and implants. Long Act Inject Implant. 2012;167–94

  9. Kim KK, Pack DW. Microspheres for drug delivery. In: Ferrari M, Lee AP, Lee JL, editors. Biol Biomed Nanotechnol. 1st ed. Springer; 2006. p. 19–50

  10. Rogers TL, Wallick D. Reviewing the use of ethylcellulose, methylcellulose and hypromellose in microencapsulation Part 2: Techniques used to make microcapsules. Drug Dev Ind Pharm. 2011;37:1259–71.

    Article  CAS  Google Scholar 

  11. Kim H, Kim BR, Shin YJ, Cho S, Lee J. Controlled formation of polylysinized inner pores in injectable microspheres of low molecular weight poly(lactide-co-glycolide) designed for efficient loading of therapeutic cells. Artif Cells, Nanomedicine Biotechnol. Taylor & Francis; 2018;46:S233–46

  12. Kim D, Han TH, Hong SC, Park SJ, Lee YH, Kim H, et al. PLGA microspheres with alginate-coated large pores for the formulation of an injectable depot of donepezil hydrochloride. Pharmaceutics. 2020;12

  13. Nkanga CI, Fisch A, Rad-Malekshahi M, Romic MD, Kittel B, Ullrich T, et al. Clinically established biodegradable long acting injectables: an industry perspective. Adv Drug Deliv Rev [Internet]. 2020;167:19–46. Available from: https://www.sciencedirect.com/science/article/pii/S0169409X20302179

  14. Simões MF, Pinto RMA, Simões S. Hot-melt extrusion in the pharmaceutical industry: toward filing a new drug application. Drug Discov Today [Internet]. Elsevier Ltd; 2019;24:1749–68. Available from: https://doi.org/10.1016/j.drudis.2019.05.013

  15. Tambe S, Jain D, Agarwal Y, Amin P. Hot-melt extrusion: highlighting recent advances in pharmaceutical applications. J Drug Deliv Sci Technol. Elsevier B.V.; 2021;63:102452

  16. Sarabu S, Bandari S, Kallakunta VR, Tiwari R, Patil H, Repka MA. An update on the contribution of hot-melt extrusion technology to novel drug delivery in the twenty-first century: part II. Expert Opin Drug Deliv. 2019;16:567–82.

    Article  CAS  Google Scholar 

  17. Kallakunta VR, Sarabu S, Bandari S, Tiwari R, Patil H, Repka MA. An update on the contribution of hot-melt extrusion technology to novel drug delivery in the twenty-first century: part I. Expert Opin Drug Deliv. 2019;16:539–50.

    Article  CAS  Google Scholar 

  18. Petrovick GF, Breitkreutz J, Pein-Hackelbusch M. Taste-masking properties of solid lipid based micropellets obtained by cold extrusion-spheronization. Int J Pharm. Elsevier B.V.; 2016;506:361–70

  19. Young CR, Koleng JJ, McGinity JW. Properties of drug-containing spherical pellets produced by a hot-melt extrusion and spheronization process. J Microencapsul. 2003;20:613–25.

    Article  CAS  Google Scholar 

  20. Young CR, Dietzsch C, McGinity JW. Compression of controlled-release pellets produced by a hot-melt extrusion and spheronization process. Pharm Dev Technol. 2005;10:133–9.

    Article  CAS  Google Scholar 

  21. Schilling SU, McGinity JW. Novel application of hot-melt extrusion for the preparation of monolithic matrices containing enteric-coated particles. Int J Pharm. Elsevier B.V.; 2010;400:24–31

  22. Yang Y, Shen L, Li J, Shan WG. Preparation and evaluation of metoprolol tartrate sustained-release pellets using hot melt extrusion combined with hot melt coating. Drug Dev Ind Pharm. Taylor & Francis; 2017;43:939–46

  23. Treffer D, Wahl PR, Hörmann TR, Markl D, Schrank S, Jones I, et al. In-line implementation of an image-based particle size measurement tool to monitor hot-melt extruded pellets. Int J Pharm [Internet]. Elsevier B.V.; 2014;466:181–9. Available from: https://doi.org/10.1016/j.ijpharm.2014.03.022

  24. Speer I, Lenhart V, Preis M, Breitkreutz J. Prolonged release from orodispersible films by incorporation of diclofenac-loaded micropellets. Int J Pharm [Internet]. Elsevier; 2019;554:149–60. Available from: https://doi.org/10.1016/j.ijpharm.2018.11.013

  25. Alshetaili AS, Almutairy BK, Tiwari RV, Morott JT, Alshehri SM, Feng X, et al. Preparation and evaluation of hot-melt extruded patient-centric ketoprofen mini-tablets. Physiol Behav. 2016;13:730–41.

    CAS  Google Scholar 

  26. Alshetaili AS, Almutairy BK, Alshahrani SM, Ashour EA, Tiwari RV, Alshehri SM, et al. Optimization of hot melt extrusion parameters for sphericity and hardness of polymeric face-cut pellets. Drug Dev Ind Pharm. 2016;42:1833–41.

    Article  CAS  Google Scholar 

  27. Agimelen OS, Hamilton P, Haley I, Nordon A, Vasile M, Sefcik J, et al. Estimation of particle size distribution and aspect ratio of non-spherical particles from chord length distribution. Chem Eng Sci. 2015;123:629–40.

    Article  CAS  Google Scholar 

  28. Hamilton Company. Needle Gauge Chart

  29. Ramstack M, Riley G, Zale S, Hotz J, Johnson O. Preparation of injectable suspensions having improved injectability. 2002

  30. Zale S, Ramstack M, Hotz J, Riley G, Johnson O. Preparation of injectable suspensions having improved injectability. Alkernes Controlled Therapeutics, Inc. 2010

  31. Sarmadi M, Behrens AM, McHugh KJ, Contreras HTM, Tochka ZL, Lu X, et al. Modeling, design, and machine learning-based framework for optimal injectability of microparticle-based drug formulations. Sci Adv. 2020;6:1–14.

    Article  Google Scholar 

  32. Hare C, Ghadiri M. The influence of aspect ratio and roughness on flowability. AIP Conf Proc. 2013;1542:887–90.

    Article  Google Scholar 

  33. Horio T, Yasuda M, Matsusaka S. Effect of particle shape on powder flowability of microcrystalline cellulose as determined using the vibration shear tube method. Int J Pharm. Elsevier B.V.; 2014;473:572–8

  34. Al-Itry R, Lamnawar K, Maazouz A. Biopolymer blends based on poly (lactic acid): Shear and elongation rheology/structure/blowing process relationships. Polymers (Basel). 2015;7:939–62.

    Article  CAS  Google Scholar 

  35. Petersmann S, Spoerk M, Van De Steene W, Üçal M, Wiener J, Pinter G, et al. Mechanical properties of polymeric implant materials produced by extrusion-based additive manufacturing. J Mech Behav Biomed Mater [Internet]. Elsevier Ltd; 2020;104:103611. Available from: https://doi.org/10.1016/j.jmbbm.2019.103611

  36. Spoerk M, Sapkota J, Weingrill G, Fischinger T, Arbeiter F, Holzer C. Shrinkage and warpage optimization of expanded-perlite-filled polypropylene composites in extrusion-based additive manufacturing. Macromol Mater Eng. 2017;302:1700143.

    Article  Google Scholar 

  37. Liu S, Qin S, He M, Zhou D, Qin Q, Wang H. Current applications of poly(lactic acid) composites in tissue engineering and drug delivery. Compos Part B Eng. Elsevier Ltd; 2020;199:108238

  38. Siepmann F, Le Brun V, Siepmann J. Drugs acting as plasticizers in polymeric systems: a quantitative treatment. J Control Release. 2006;115:298–306.

    Article  CAS  Google Scholar 

  39. Watt RP, Khatri H, Dibble ARG. Injectability as a function of viscosity and dosing materials for subcutaneous administration. Int J Pharm. Elsevier B.V.; 2019;554:376–86

  40. Dammerman R, Kim S, Adera M, Schwarz A. Pharmacokinetics and Safety of Risperidone Subcutaneous Implants. Clin Pharmacol Drug Dev. 2018;7:298–310.

    Article  CAS  Google Scholar 

  41. Lima DB, Almeida RD, Pasquali M, Borges SP, Fook ML, Lisboa HM. Physical characterization and modeling of chitosan/peg blends for injectable scaffolds. Carbohydr Polym Elsevier Ltd. 2018;189:238–49.

    Article  CAS  Google Scholar 

  42. Brown LR. Commercial challenges of protein drug delivery. Expert Opin Drug Deliv. 2005;2:29–42.

    Article  Google Scholar 

  43. Koshy ST, Zhang DKY, Grolman JM, Stafford AG, Mooney DJ. Injectable nanocomposite cryogels for versatile protein drug delivery. Acta Biomater. 2018;65:36–43.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Dr. Peter Böhling, Aygün Dogan, and Carolina Patricia Alva Zúñiga from the Research Center Pharmaceutical Engineering as well as Christoph Zauner and Michael Mayer from Fresenius Kabi, Austria, for their support with the injectability experiments and data treatment.

Funding

The Research Center Pharmaceutical Engineering (RCPE) is funded within the framework of COMET—Competence Centers for Excellent Technologies by BMK, BMAW, Land Steiermark, and SFG. The COMET program is managed by the FFG.

Author information

Authors and Affiliations

Authors

Contributions

Martin Spoerk: Conceptualization, methodology, validation, formal analysis, data curation, writing (original draft), writing (review and editing), visualization, supervision, project administration.

Ioannis Koutsamanis: Methodology, validation, formal analysis, investigation, data curation, writing (original draft), visualization.

Andreas Kottlan: Methodology, validation, data curation, writing—review and editing.

Christian Makert: Methodology, writing—review and editing.

Michael Piller: Methodology, formal analysis, writing—review and editing.

Manuel Rajkovaca: Methodology, writing—review and editing.

Amrit Paudel: Methodology, writing—review and editing.

Johannes Khinast: Methodology, writing—review and editing.

Corresponding author

Correspondence to Martin Spoerk.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (MP4 5.01 MB)

Supplementary file2 (MP4 3.86 MB)

Supplementary file3 (DOCX 24.7 KB)

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Spoerk, M., Koutsamanis, I., Kottlan, A. et al. Continuous Processing of Micropellets via Hot-Melt Extrusion. AAPS PharmSciTech 23, 264 (2022). https://doi.org/10.1208/s12249-022-02405-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1208/s12249-022-02405-7

Keywords

Navigation